FDA to Investigate Diabetes Drug Saxagliptin for Possible Heart Failure Risk
Marketed as Onglyza and Kombiglyze XR, drug appears to have no effect on heart attack or stroke riskContinue Reading
Marketed as Onglyza and Kombiglyze XR, drug appears to have no effect on heart attack or stroke riskContinue Reading
Researchers suggest their findings could lead to the development of new treatments for the diseaseContinue Reading
The hope: to eliminate daily injections for those with diabetes, but much testing remains to be doneContinue Reading
If early results translate to humans, need for daily injections might be eliminated in future, researchers sayContinue Reading
British study also found reduced risk with other fermented dairy productsContinue Reading
When you shiver, your body converts white fat to healthier brown fat, study findsContinue Reading
Commit to eating healthierContinue Reading
Firefighters who followed it most closely saw less weight gain, lower risk of heart troubleContinue Reading
However, device didn’t perform as well in kids as in adults, FDA saysContinue Reading
Study found no effect, but longer-term trials may be needed to see a benefit, experts addContinue Reading
© 2021 WeeklyMD.com - All Rights Reserved.